GlassScriptPhysician profile
Herman B Cheek
NPI 1265493027
$3,521.16
in general payments reported to CMS, 2019-2025
19 companies · $286 in 2025
The $286 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $397 · 2020: $713 · 2021: $245 · 2022: $642 · 2023: $430 · 2024: $809 · 2025: $286.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,321 · Travel and Lodging: $203.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,321.29 |
| Travel and Lodging | $203.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,031.75 | 2019-2024 | |
| Abiomed | $723.62 | 2019-2025 | Impella |
| Shockwave Medical, INC | $355.34 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $320.35 | 2019-2025 | Optis, Coroflow, Pressurewire |
| Inari Medical, INC. | $166.89 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Astrazeneca Pharmaceuticals LP | $161.34 | 2019-2023 | Wainua, Lokelma |
| Siemens Medical Solutions USA, INC. | $142.04 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $114.20 | 2019-2025 | Lifevest |
| Boston Scientific Corporation | $103.38 | 2019-2024 | Ekosonic |
| Medtronic, INC. | $100.05 | 2021-2023 | Telescope |
| Amgen INC. | $97.83 | 2022 | |
| Corindus INC. | $82.34 | 2019 | |
| Esperion Therapeutics, INC. | $47.00 | 2022 | |
| Cordis US Corp. | $23.61 | 2022 | |
| Biosense Webster, INC. | $18.28 | 2023 | Carto 3 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $15.07 | 2019 | |
| Terumo Medical Corporation | $13.53 | 2023 | Tr Band, Glidesheath Slender |
| Cardiovascular Systems INC. | $4.54 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Herman Cheek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.